Can-Fite BioPharma CANF
NYSE CANF
$2.21 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Can-Fite BioPharma (CANF) Cash from Operations (2013)

Updated

Can-Fite BioPharma's Cash from Operations came in at -$8.95 million for FY2025, compared with -$7.64 million in FY2024.

Analysis

Can-Fite BioPharma (CANF) Cash from Operations (2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Cash from Operations data covers 11 years.

  • The FY2025 figure represents the lowest annual Cash from Operations since FY2022.
  • Per Business Quant, earlier years put Cash from Operations at -$7.64 million in FY2024, -$8.44 million in FY2023, -$10.8 million in FY2022 and -$9.86 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 -1.70 Mn
API Access

Can-Fite BioPharma Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CANF&period=max&api_key=YOUR_API_KEY